Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US Medicare Cost For Part D Redesign Could Far Exceed Earlier Projections, CBO Says
Oct 03 2024
•
By
Cathy Kelly
CBO's Score Is An Attention Getter But $10bn Range In Forecast Underscores Uncertainty • Source: Shutterstock
More from Market Access
More from Pink Sheet